Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction

European Respiratory Journal

Volumn 14, Issue 4, 1999, Pages 800-805

  Diaz Jimenez J P ^a   Martinez Ballarin J E ^a   Llunell, A ^a   Farrero, E ^a   Rodriguez A ^a   Castro, M J ^a  

^a Endoscopy and Laser Unit   (Spain)

Author keywords

Advanced lung cancer; Haematoporphyrin derivative; Laser palliation; Laser photoresection; Non small cell lung cancer; Photodynamic therapy

Indexed keywords

PHOTOFRIN;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LASER SURGERY; LUNG NON SMALL CELL CANCER; MALE; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AIRWAY OBSTRUCTION; ANTINEOPLASTIC AGENTS; BIOPSY; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; DIHEMATOPORPHYRIN ETHER; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; LUNG NEOPLASMS; MIDDLE AGED; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 0345035275     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14d13.x     Document Type: Article

References (27)

1. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base Report on Lung Cancer. Cancer 1996; 77: 1947-1955.
2. Whitehouse JMA. Management of lung cancer. Report of working group. Current Clinical Practices 1994; 1.
3. Carrol M, Morgan S, Yarnold JA, Hill JM, Wright NM. Prospective evaluation of a watch policy in patients with inoperable non-small cell cancer. Eur J Cancer Clinic Oncol 1986; 22: 1352-1356.
4. Moghissi K, Dixon K, Hudson E, Stringer M, Brown S. Endoscopic laser therapy in malignant tracheobronchial obstruction using sequential Nd-YAG laser and photodynamic therapy. Thorax 1997; 52: 281-283.
5. Diaz-Jimenez JP, Martinez-Ballarin JI, Farrero-Muñoz E, Kovitz KL, Castro-Serrano MJ. Video Endoscopy for laser photoresection in tracheobronchial pathology: some considerations after 9 years experience with 2105 treatments. Diagnos Therap Endosc 1995; 2: 79-87.
6. Cavallieri S, Foccoli P, Toninelli C, et al. Nd-YAG laser therapy in lung cancer: an 11-year experience with 2,253 applications in 1,585 patients. J Bronchol 1994; 1: 105-111.
7. Dumon JF, Reboud E, Garbe L, Aucomte F, Meris B. Treatment of tracheobronchial lesions by laser photoresection. Chest 1982; 81: 278-284.
8. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
9. Edell ES, Cortese DA. Photodynamic Therapy. Clin Chest Med 1995; 16: 455-463.
10. Henderson BW, Bellnier DA. Tissue localisation of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found Symp 1989; 146: 112-125.
11. Jori G. Tumor photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B 1996; 36: 87-93.
12. Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol 1989; 49: 299-304.
13. Hayata Y, Kato H, Konaka C et al. Photoradiation therapy with hematoporphyrin derivative in early stage I lung cancer. Chest 1984; 86: 169-177.
14. Cortese DA, Edell ES, Kinsey JH. Photodynamic Therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72: 595-602.
15. Cortese DA, Kinsey JH, Woolner LB, et al. Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. Mayo Clin Proc 1979; 54: 635-641.
16. Vermilen P, Berghans T, Roufosse C, et al. Diagnosis and treatment of early-stage bronchial cancer: current status. Rev Med Brux 1997; 18: 347-352.
17. Hayata Y, Kato H Konakla C, et al. Photoradiation therapy in early stage cancer of the lung, esophagus and stomach. In: Cubbedu AA, ed. Porphyrins in Tumor Phototherapy: New York Plenum, 1984: 405-412.
18. McCaughan JS Jr., Williams TE. Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg 1997; 114: 940-946. discussion 946-947.
19. Sutedja T, Baas P, Stewart F, van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer. Europ J Cancer 1992; 28A: 1370-1373.
20. LoCicero J, Metzdorff M, Almgren C. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest 1990; 98: 97-100.
21. Braichotte DR, Wagnieres GA, Bays R, Monnier P, van den Bergh HE. Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus and the bronchi. Cancer 1996; 75: 2768-2778.
22. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102: 1319-1322.
23. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993; 10: 1844-1845.
24. Okunaka T, Kato H, Konaka C, et al. Photodynamic therapy for multiple primary, bronchogenic carcinoma. Cancer 1991; 68: 253-258.
25. Imamura S, Kusunoki Y, Takifuji N, et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 1994; 73: 1608-1614.
26. Sutedja G. Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchol 1994; 1: 295-298.
27. McCaughan JSJ. Photodynamic therapy versus ND-YAG laser treatment of endobronchial or esophageal malignancies. In: Spinelli P, Del Fante M, Marchesini R, Del Fante M, eds. Photodynamic Therapy and Biomedical Lasers. New York: Elsevier, 1992; 23-26.